Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Article abstract-We studied the apolipoprotein E (apoE) allele frequencies in 65 Chinese patients with late-onset Alzheimer's disease (AD) and 82 age- and sex-matched controls. The apoE epsilon 4 allele frequency was significantly higher in the AD group than in the control group (0.169 versus 0.067, p < 0.01). There were five homozygotes for epsilon 4 in the AD group but none among the controls. The odds ratio for AD was 1.6 for epsilon 4 heterozygotes. The age at onset was lower with the presence of the epsilon 4 allele and higher with the epsilon 2 allele, although neither of these differences reached statistical significance.
The association between apoE alleles and AD previously reported in Caucasian populations was also present in this first reported study in Chinese.However, the lower epsilon 4 frequency in the Chinese population is compatible with previous reports of lower prevalence of AD compared with the prevalence of multi-infarct dementia.
NEUROLOGY 1996;46: 146-149
- Copyright 1996 by Advanstar Communications Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
ARTICLES
Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's diseaseRelation to apolipoprotein E polymorphismM. Lehtovirta, H. Soininen, S. Helisalmi et al.Neurology, February 01, 1996 -
Article
Apolipoprotein E-epsilon 2 and Alzheimer's diseaseGenotype influences pathologic phenotypeC. F. Lippa, T. W. Smith, A. M. Saunders et al.Neurology, February 01, 1997 -
Article
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variantJ. M. Olichney, L. A. Hansen, D. Galasko et al.Neurology, July 01, 1996 -
Articles
The impact of apolipoprotein E4 on cause of death in Alzheimer's diseaseJ. M. Olichney, M. N. Sabbagh, C. R. Hofstetter et al.Neurology, July 01, 1997